查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1756483

免疫组织化学市场，按产品、应用、最终用户、国家和地区 - 产业分析、市场规模、市场份额及预测（2024 年至 2032 年）

Immunohistochemistry Market, By Offering, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 387 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年免疫组织化学市场规模价值 28.76 亿美元，2024 年至 2032 年的复合年增长率为 6.6%。

免疫组织化学市场-市场动态

慢性病盛行率不断上升

慢性疾病（尤其是癌症）发生率的上升是免疫组织化学市场的主要驱动力。免疫组化 (IHC) 透过检测组织样本中的特定生物标记物，在癌症的准确诊断和分类中发挥着至关重要的作用。这有助于制定个人化治疗方案，并改善患者的预后。随着人口老化和生活方式因素导致全球癌症和其他慢性疾病发生率上升，对 IHC 等精准诊断技术的需求也日益增长。此外，IHC 在研究和药物开发中的应用日益广泛，透过支持标靶治疗和精准医疗的进步，进一步推动了市场的成长。

免疫组织化学市场—关键见解

根据我们的研究分析师，全球免疫组织化学市场预计在 2024 年至 2032 年期间的复合年增长率约为 6.6%。

按 2023 年产品细分，抗体类别占据了市场主导地位。

根据应用，诊断应用部门在 2023 年创造了最多的收入。

按地区划分，2023年北美是收入最高的地区。

免疫组织化学市场-細項分析：

全球免疫组织化学市场分为四大类：产品、应用、最终用户和地区。

免疫组织化学 (IHC) 市场细分为抗体、试剂、设备、试剂盒和软体。抗体对于特异性结合组织样本中的标靶抗原至关重要，使其成为 IHC 过程中的关键组成部分。试剂支援染色和可视化的各个阶段，而设备包括用于执行和分析测试的显微镜、玻片扫描仪和自动染色系统。试剂盒提供即用型抗体和试剂组合，简化了实验室的工作流程。软体解决方案有助于影像分析和资料管理，从而提高准确性和效率。在这些细分市场中，抗体占据市场主导地位，因为它们在识别生物标记方面发挥着重要作用，对多样化和高特异性抗体的需求旺盛，并且持续创新，从而推动了全球诊断和研究应用领域的巨大收入和应用。

免疫组织化学 (IHC) 市场按应用分为诊断应用、研究应用和法医应用。诊断应用是指使用 IHC 技术透过检测患者组织样本中的特定生物标记来识别和分类疾病，尤其是癌症。研究应用包括在实验室和学术环境中使用 IHC 研究疾病机制、药物开发和生物标记发现。法医应用在刑事调查中使用 IHC 来识别组织类型和细胞成分。其中，诊断应用占据了最大的市场份额，因为对精准和早期疾病检测的需求日益增长，尤其是在肿瘤学领域。慢性病盛行率的上升和个人化医疗的日益普及，强烈推动了对临床诊断中 IHC 的需求，使其成为全球主要的应用领域。

免疫组织化学市场-地理洞察

从地理分布来看，免疫组织化学市场分布在北美、亚太地区、拉丁美洲、欧洲、中东和非洲。这些地区根据业务来源国进一步划分。

北美是免疫组织化学市场的主导地区，其驱动力源自于先进的医疗基础设施、创新诊断技术的广泛应用以及大量的科研投入。大型製药和生物技术公司的入驻，加上政府对癌症和慢性病研究的大力投入，共同推动了市场的成长。此外，人们对个人化医疗和早期疾病诊断的认识不断提高，也推动了免疫组织化学 (IHC) 技术的广泛应用。美国凭藉对精准诊断工具的强劲需求、完善的报销政策以及庞大的患者群体，在该地区处于领先地位，这使得北美成为全球免疫组织化学市场的主要收入来源。

欧洲凭藉其发达的医疗保健体係以及日益增长的癌症和其他慢性疾病盛行率，在免疫组织化学市场中占有重要份额。在政府措施和研究资金的支持下，德国、英国和法国等国家在采用先进的免疫组织化学 (IHC) 技术方面处于领先地位。精准医疗日益受到重视，生物製药研究活动也日益活跃，这进一步推动了免疫组织化学 (IHC) 的需求。欧洲也受益于强大的诊断实验室和学术机构网络，这促进了免疫组织化学 (IHC) 在临床诊断和研究中的应用，使其成为全球领先的区域市场。

免疫组织化学市场-竞争格局：

免疫组织化学市场由赛默飞世尔科技、丹纳赫集团、罗氏公司和伯乐实验室等老牌企业主导。这些公司高度重视创新、品质和合规性，提供用于临床诊断和研究的广泛抗体、试剂、试剂盒和仪器产品组合。他们投入大量资金进行研发，以提高产品的敏感度和特异性，满足日益增长的个人化医疗和精准疾病检测需求。新兴公司也透过开发新技术、推动竞争来贡献力量，从而促进免疫组织化学方法的持续改进，并扩大其在全球医疗保健和研究领域的应用。

最新动态：

2025 年 3 月，赛默飞世尔科技公司推出了全新的自动化 IHC 染色平台，旨在提高临床实验室的通量和可重复性。

2024 年 12 月，丹纳赫收购了一家领先的数位病理软体公司，以增强其 IHC 影像分析能力并整合 AI 驱动的诊断。

目录

第一章：免疫组织化学市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 免疫组织化学市场片段（依产品分类）
    • 免疫组织化学市场片段（按应用）
    • 免疫组织化学市场片段（按最终用户）
    • 免疫组织化学市场（按国家/地区）
    • 免疫组织化学市场片段（按地区）
  • 竞争洞察

第三章：免疫组织化学主要市场趋势

  • 免疫组织化学市场驱动因素
    • 市场驱动因素的影响分析
  • 免疫组织化学市场限制
    • 市场限制的影响分析
  • 免疫组织化学市场机会
  • 免疫组织化学市场未来趋势

第四章：免疫组织化学产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：免疫组织化学市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • 新冠疫情后影响分析
    • 表现最佳的市场区隔
    • 边际成长细分市场
    • 最鬆散的细分市场
    • 边际损失部分

第六章：免疫组织化学市场格局

  • 2023年免疫组织化学市占分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：免疫组织化学市场－依产品分类

  • 概述
    • 按产品细分市场占有率分析
    • 抗体
      • 一抗
      • 二抗
      • 单株抗体
      • 多株抗体抗体
    • 试剂
      • 组织学染色
      • 封闭血清和试剂
      • 显色底物
      • 固定试剂
      • 稀释剂
      • 有机溶剂
      • 蛋白水解酶
      • 其他试剂
    • 装置
      • 玻片染色系统
      • 组织处理系统
      • 幻灯片扫描仪
      • 其他设备
    • 套件
      • 人体免疫组织化学试剂盒
      • 动物免疫组织化学试剂盒
    • 软体

第 8 章：免疫组织化学市场 - 按应用

  • 概述
    • 按应用细分市场占有率分析
    • 诊断应用
      • 癌症
      • 传染病
      • 肾臟疾病
      • 自体免疫疾病
      • 神经系统疾病
      • 其他疾病
    • 研究应用
      • 药物开发与测试
      • 其他研究应用
    • 法医应用

第九章：免疫组织化学市场－按最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 医院和诊断实验室
    • 学术研究机构和合约研究组织
    • 其他最终用户

第 10 章：免疫组织化学市场-按地域划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美免疫组织化学主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模及预测（依产品分类）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲免疫组织化学主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模及预测（依产品分类）
    • 欧洲市场规模和预测，按应用
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区免疫组织化学主要製造商
    • 亚太市场规模及预测（按国家/地区）
    • 亚太市场规模及预测（依产品分类）
    • 亚太市场规模及预测（按应用）
    • 亚太市场规模及预测（依最终用户）
    • 印度
    • 中国
    • 韩国
    • 日本
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲免疫组织化学主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（依产品分类）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲的免疫组织化学主要製造商
    • 中东和非洲市场规模及预测（按国家/地区）
    • 中东和非洲市场规模及预测（依产品分类）
    • 中东和非洲市场规模和预测（按应用）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 11 章：免疫组织化学产业主要供应商分析

  • 竞争仪錶板
  • 公司简介
    • F. Hoffmann-La Roche Ltd
    • Danaher Corporation
    • Agilent Technologies, Inc
    • Thermo Fisher Scientific Inc.
    • Merck Kgaa
    • Bio-Rad Laboratories, Inc
    • Bio-Techne
    • Becton, Dickinson And Company
    • Takara Bio Inc.
    • Enzo Biochem Inc.
    • Sino Biological, Inc.
    • Sakura Finetek Japan Co., Ltd.
    • Cell Signaling Technology, Inc.
    • Bio Sb
    • Origene Technologies, Inc
    • Eaglebio
    • Biocare Medical, Llc
    • Elabscience Bionovation Inc.
    • Biogenex
    • Diagnostic Biosystems Inc.
    • Histo-Line Laboratories
    • Rockland Immunochemicals, Inc.
    • Candor Bioscience Gmbh
    • Genemed Biotechnologies, Inc.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5291

REPORT HIGHLIGHT

Immunohistochemistry Market size was valued at USD 2,876 Million in 2024, expanding at a CAGR of 6.6% from 2024 to 2032.

The Immunohistochemistry (IHC) market refers to the industry focused on the production and sale of reagents, antibodies, detection kits, instruments, and related services used for IHC techniques. Immunohistochemistry is a laboratory method that uses antibodies to detect specific antigens in tissue samples, aiding in disease diagnosis, especially cancer, and research. The market encompasses products used in hospitals, diagnostic labs, research institutes, and pharmaceutical companies. Growth in this market is driven by rising prevalence of chronic diseases, technological advancements, and increasing demand for personalized medicine and accurate diagnostic tools globally.

Immunohistochemistry Market- Market Dynamics

Increasing Prevalence of Chronic Diseases

The rising incidence of chronic diseases, especially cancer, is a major driver of the immunohistochemistry market. IHC plays a crucial role in accurately diagnosing and classifying cancers by detecting specific biomarkers in tissue samples. This enables personalized treatment plans and better patient outcomes. As global cancer rates and other chronic illnesses grow due to aging populations and lifestyle factors, the demand for precise diagnostic techniques like IHC increases. Additionally, the expanding use of IHC in research and drug development further propels market growth by supporting advancements in targeted therapies and precision medicine.

Immunohistochemistry Market- Key Insights

According to our research analyst, the global Immunohistochemistry Market is expected to develop at a CAGR of approximately 6.6% between 2024-2032.

Segmented by Offerings in 2023, the Antibodies category dominated the market.

Based on Application, the Diagnostic Applications segment generated the most income in 2023.

On the basis of region, in 2023, North America was the region with the highest revenue.

Immunohistochemistry Market- Segmentation Analysis:

The global Immunohistochemistry Market is divided into Four categories: Offering, Application, End User, and Region.

The Immunohistochemistry (IHC) market is segmented by offering into Antibodies, Reagents, Equipment, Kits, and Software. Antibodies are essential for specifically binding to target antigens in tissue samples, making them a critical component in IHC processes. Reagents support various stages of staining and visualization, while Equipment includes microscopes, slide scanners, and automated staining systems used to perform and analyze tests. Kits provide ready-to-use combinations of antibodies and reagents, simplifying workflows for laboratories. Software solutions aid in image analysis and data management, enhancing accuracy and efficiency. Among these segments, Antibodies dominate the market due to their fundamental role in identifying biomarkers, high demand for diverse and highly specific antibodies, and continuous innovations, which drive significant revenue and adoption across diagnostic and research applications worldwide.

The Immunohistochemistry (IHC) market is categorized by application into Diagnostic Applications, Research Applications, and Forensic Applications. Diagnostic applications represent the use of IHC techniques to identify and classify diseases, particularly cancers, by detecting specific biomarkers in patient tissue samples. Research applications involve studying disease mechanisms, drug development, and biomarker discovery using IHC in laboratories and academic settings. Forensic applications use IHC for identifying tissue types and cellular components in criminal investigations. Among these, Diagnostic Applications hold the largest share of the market due to the growing need for precise and early disease detection, especially in oncology. The rising prevalence of chronic diseases and increasing adoption of personalized medicine strongly drive the demand for IHC in clinical diagnostics, making it the dominant application segment globally.

Immunohistochemistry Market- Geographical Insights

Geographically, the Immunohistochemistry Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America is a dominant region in the Immunohistochemistry market, driven by advanced healthcare infrastructure, high adoption of innovative diagnostic technologies, and significant research investments. The presence of major pharmaceutical and biotechnology companies, coupled with strong government funding for cancer and chronic disease research, fuels market growth. Additionally, increasing awareness about personalized medicine and early disease diagnosis supports widespread use of IHC techniques. The U.S. leads the region with robust demand for precise diagnostic tools, well-established reimbursement policies, and a large patient pool, making North America a key revenue contributor in the global immunohistochemistry market.

Europe holds a significant share in the Immunohistochemistry market due to its well-developed healthcare systems and increasing prevalence of cancer and other chronic diseases. Countries like Germany, the UK, and France are at the forefront of adopting advanced IHC technologies, supported by government initiatives and research funding. The rising focus on precision medicine and expanding biopharmaceutical research activities further drive demand. Europe also benefits from a strong network of diagnostic laboratories and academic institutions, promoting the use of IHC for both clinical diagnostics and research purposes, positioning it as a dominant regional market globally.

Immunohistochemistry Market- Competitive Landscape:

The Immunohistochemistry market is dominated by established players like Thermo Fisher Scientific, Danaher Corporation, F. Hoffmann-La Roche Ltd, and Bio-Rad Laboratories. These companies focus heavily on innovation, quality, and regulatory compliance, offering a broad portfolio of antibodies, reagents, kits, and instruments for clinical diagnostics and research. They invest substantially in R&D to enhance product sensitivity and specificity, catering to the growing demand for personalized medicine and accurate disease detection. Emerging companies also contribute by developing novel technologies, driving competition that fosters continuous improvement in IHC methodologies and expands adoption in healthcare and research sectors worldwide.

Recent Developments:

In March 2025, Thermo Fisher Scientific Inc. launched a new automated IHC staining platform designed to improve throughput and reproducibility in clinical laboratories.

In December 2024, Danaher Corporation acquired a leading digital pathology software firm to enhance its IHC image analysis capabilities and integrate AI-driven diagnostics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IMMUNOHISTOCHEMISTRY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • F. Hoffmann-La Roche Ltd
  • Danaher Corporation
  • Agilent Technologies, Inc
  • Thermo Fisher Scientific Inc.
  • Merck Kgaa
  • Bio-Rad Laboratories, Inc
  • Bio-Techne
  • Becton, Dickinson And Company
  • Takara Bio Inc.
  • Enzo Biochem Inc.
  • Sino Biological, Inc.
  • Sakura Finetek Japan Co., Ltd.
  • Cell Signaling Technology, Inc.
  • Bio Sb
  • Origene Technologies, Inc
  • Eaglebio
  • Biocare Medical, Llc
  • Elabscience Bionovation Inc.
  • Biogenex
  • Diagnostic Biosystems Inc.
  • Histo-Line Laboratories
  • Rockland Immunochemicals, Inc.
  • Candor Bioscience Gmbh
  • Genemed Biotechnologies, Inc.
  • Others

GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING - MARKET ANALYSIS, 2019 - 2032

  • Antibodies
  • Primary Antibodies
  • Secondary Antibodies
  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Reagents
  • Histological Stains
  • Blocking Sera And Reagents
  • Chromogenic Substrates
  • Fixation Reagents
  • Diluents
  • Organic Solvents
  • Proteolytic Enzymes
  • Other Reagents
  • Equipment
  • Slide-Staining Systems
  • Tissue Processing Systems
  • Slide Scanners
  • Other Equipment
  • Kits
  • Human Immunohistochemistry Kits
  • Animal Immunohistochemistry Kits
  • Software

GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032

  • Diagnostic Applications
  • Cancer
  • Infectious Diseases
  • Nephrological Diseases
  • Autoimmune Diseases
  • Neurological Diseases
  • Other Diseases
  • Research Applications
  • Drug Development And Testing
  • Other Research Applications
  • Forensic Applications

GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032

  • Hospitals And Diagnostic Laboratories
  • Academic & Research Institutes And Contract Research Organizations
  • Other End Users

GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Immunohistochemistry Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Immunohistochemistry Market Snippet by Offerings
    • 2.1.2. Immunohistochemistry Market Snippet by Application
    • 2.1.3. Immunohistochemistry Market Snippet by End User
    • 2.1.4. Immunohistochemistry Market Snippet by Country
    • 2.1.5. Immunohistochemistry Market Snippet by Region
  • 2.2. Competitive Insights

3. Immunohistochemistry Key Market Trends

  • 3.1. Immunohistochemistry Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Immunohistochemistry Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Immunohistochemistry Market Opportunities
  • 3.4. Immunohistochemistry Market Future Trends

4. Immunohistochemistry Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Immunohistochemistry Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Immunohistochemistry Market Landscape

  • 6.1. Immunohistochemistry Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Immunohistochemistry Market - By Offerings

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Offerings, 2023 & 2032 (%)
    • 7.1.2. Antibodies
      • 7.1.2.1. Primary Antibodies
      • 7.1.2.2. Secondary Antibodies
      • 7.1.2.3. Monoclonal Antibodies
      • 7.1.2.4. Polyclonal Antibodies
    • 7.1.3. Reagents
      • 7.1.3.1. Histological Stains
      • 7.1.3.2. Blocking Sera And Reagents
      • 7.1.3.3. Chromogenic Substrates
      • 7.1.3.4. Fixation Reagents
      • 7.1.3.5. Diluents
      • 7.1.3.6. Organic Solvents
      • 7.1.3.7. Proteolytic Enzymes
      • 7.1.3.8. Other Reagents
    • 7.1.4. Equipment
      • 7.1.4.1. Slide-Staining Systems
      • 7.1.4.2. Tissue Processing Systems
      • 7.1.4.3. Slide Scanners
      • 7.1.4.4. Other Equipment
    • 7.1.5. Kits
      • 7.1.5.1. Human Immunohistochemistry Kits
      • 7.1.5.2. Animal Immunohistochemistry Kits
    • 7.1.6. Software

8. Immunohistochemistry Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Diagnostic Applications
      • 8.1.2.1. Cancer
      • 8.1.2.2. Infectious Diseases
      • 8.1.2.3. Nephrological Diseases
      • 8.1.2.4. Autoimmune Diseases
      • 8.1.2.5. Neurological Diseases
      • 8.1.2.6. Other Diseases
    • 8.1.3. Research Applications
      • 8.1.3.1. Drug Development and Testing
      • 8.1.3.2. Other Research Applications
    • 8.1.4. Forensic Applications

9. Immunohistochemistry Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Hospitals And Diagnostic Laboratories
    • 9.1.3. Academic & Research Institutes and Contract Research Organizations
    • 9.1.4. Other End Users

10. Immunohistochemistry Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Immunohistochemistry Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Immunohistochemistry Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Immunohistochemistry Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Immunohistochemistry Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Immunohistochemistry Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Immunohistochemistry Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. F. Hoffmann-La Roche Ltd
    • 11.2.2. Danaher Corporation
    • 11.2.3. Agilent Technologies, Inc
    • 11.2.4. Thermo Fisher Scientific Inc.
    • 11.2.5. Merck Kgaa
    • 11.2.6. Bio-Rad Laboratories, Inc
    • 11.2.7. Bio-Techne
    • 11.2.8. Becton, Dickinson And Company
    • 11.2.9. Takara Bio Inc.
    • 11.2.10. Enzo Biochem Inc.
    • 11.2.11. Sino Biological, Inc.
    • 11.2.12. Sakura Finetek Japan Co., Ltd.
    • 11.2.13. Cell Signaling Technology, Inc.
    • 11.2.14. Bio Sb
    • 11.2.15. Origene Technologies, Inc
    • 11.2.16. Eaglebio
    • 11.2.17. Biocare Medical, Llc
    • 11.2.18. Elabscience Bionovation Inc.
    • 11.2.19. Biogenex
    • 11.2.20. Diagnostic Biosystems Inc.
    • 11.2.21. Histo-Line Laboratories
    • 11.2.22. Rockland Immunochemicals, Inc.
    • 11.2.23. Candor Bioscience Gmbh
    • 11.2.24. Genemed Biotechnologies, Inc.
    • 11.2.25. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us